<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="project_funders\PMC6797873\results\search\funders\results.xml">
  <result pre="identified through global surveillance programmes and organizations such as the" exact="World Health Organization" post="(WHO). Although labelled ‘emerging’, most of these pathogens are"/>
  <result pre="Table 1 Prioritization of research and development effort by the" exact="World Health Organization" post="(WHO) for pathogens, February 2018 13 Pathogen Additional pathogens"/>
  <result pre="prioritize vaccine efforts in these respective contexts 61, while the" exact="Department of Health," post="together with Innovate UK, has supported R&amp;amp;D of vaccine"/>
  <result pre="for such products may also be considered and granted by" exact="Health Canada." post="In the European Union, the EMA supports early patient"/>
  <result pre="of rift valley fever vaccine development. Vaccines (Basel)2017; 5:29. 52collab:" exact="World Health Organization" post="(WHO) . The use of veterinary vaccines for prevention"/>
  <result pre="infectious diseases. Available at: https://www.who.int/reseatch-observatory/monitoring/processes/health_products (accessed 18 December 2018). 76collab:" exact="World Health Organization" post=". WHO vaccine pipeline tracker. Available at: https://docs.google.com/spreadsheets/d/19otvINcayJURCMg76xWO4KvuyedYbMZDcXqbyJGdcZM/pubhtml# (accessed"/>
 </snippets>
</snippetsTree>
